Subscribe to RSS
DOI: 10.1055/s-2004-815533
Kava Hepatotoxicity: Are we any Closer to the Truth?
Publication History
Received: December 1, 2003
Accepted: January 31, 2004
Publication Date:
23 March 2004 (online)

Abstract
In recent years, kava kava (Piper methysticum, Forst. f., Piperaceae) has been implicated in a number of liver failure cases. Ever since this has kept the scientific world busy. Even though, on closer inspection, the majority of the case reports are probably not connected to kava intake, hepatotoxic effects of kava cannot generally be ruled out. In this article the major theories as to the mechanism of kava hepatotoxicity are summarized. But in spite of all these hypotheses, there is still no satisfactory answer. In any case, further studies, that might hopefully restore the reputation of kava, are required.
Key words
Kava kava - Piper methysticum - Piperaceae - kavalactones - hepatotoxicity - herb-drug interactions - pipermethystin - alkaloid
References
-
1 BfArM (Federal Institute for Drugs and Medicinal Products in Germany): http://www.bfarm.de/de/Arzneimittel/am_sicher/stufenpl/Besch-Kava-Final.pdf.
- 2 Russmann S, Lauterburg B H, Helbling A. Kava hepatotoxicity. Ann Intern Med. 2001; 135 68-9
- 3 Campo J V, McNabb J, Perel J M, Mazariegos G V, Hasegawa S L, Reyes J. Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry. 2002; 41 631-2
- 4 McGhee H W. Hepatic toxicity possibly associated with kava-containing products - United States, Germany and Switzerland 1999 - 2002. JAMA. 2003; 289 36-7
- 5 Gow P J, Connelly N J, Hill R L, Crowley P, Angus P W. Fatal fulminant hepatic failure induced by a natural therapy containing kava. MJA. 2003; 178 442-3
- 6 Brauer R B, Stangl M, Stewart J R, Pfab R, Becker K. Acute liver failure after administration of the herbal tranquilizer kava-kava (Piper methysticum). J Clin Psychiatry. 2003; 64 216-8
- 7 Stickel F, Baumüller H -M, Seitz K, Vasilakis D, Seitz G, Seitz H K, Schuppan D. Hepatitis induced by kava (Piper methysticum rhizoma). J Hepatol. 2003; 39 62-7
- 8 Strahl S, Ehret V, Dahm H H, Maier K P. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr. 1998; 123 1410-4
- 9 Schmidt M, Nahrstedt A. Ist kava lebertoxisch?. Dtsch Apoth Ztg. 2002; 142 1006-11
- 10 Teschke R. Kava, kavapyrones and toxic liver injury. Z Gastroenterol. 2003; 41 395-404
- 11 Schmidt M. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. J Altern Complement Med. 2003; 64 673-9
- 12 Bauer R, Kopp B, Nahrstedt A. Relevant hepatotoxic effects of kava still need to be proven. Planta Med. 2003; 69 971-2
- 13 Teschke R, Gaus W, Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine. 2003; 10 440-6
- 14 Loew D, Gaus W. Kava (Piper methysticum): The tragedy of a wrong judgement. Z Phytother. 2002; 23 267-81
- 15 Mills S Y, Steinhoff B. Kava-kava: a lesson for the phytomedicine community. Phytomedicine. 2003; 10 261-2
Iqbal Ramzan
Faculty of Pharmacy
University of Sydney
Sydney
NSW 2006
Australia
Phone: +61-2-9351-2324
Fax: +61-2-9351-4391
Email: iqbalr@pharm.usyd.edu.au